United States Cancer Screening Market Report 2016

October 2016 | 118 pages | ID: U79496561EEEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Screening

Revenue, means the sales value of Cancer Screening

This report studies sales (consumption) of Cancer Screening in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott
• Roche
• Fujirebio Diagnostics, Inc.
• BioMérieux
• Beckman Coulter
• Clarient
• Siemens
• DiaSorin
• Qiagen
• Xeptagen
• Orion Genomics.
• Hologic, Inc.
• Quest Diagnostics
• Oncohealth Corporation
• Femasys, Inc.
• Biohit Oyj
• Sysmex
• Immunostics
• Alere

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cancer Screening in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Cancer Screening Market Report 2016

1 CANCER SCREENING OVERVIEW

1.1 Product Overview and Scope of Cancer Screening
1.2 Classification of Cancer Screening
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cancer Screening
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Screening (2011-2021)
  1.4.1 United States Cancer Screening Sales and Growth Rate (2011-2021)
  1.4.2 United States Cancer Screening Revenue and Growth Rate (2011-2021)

2 UNITED STATES CANCER SCREENING COMPETITION BY MANUFACTURERS

2.1 United States Cancer Screening Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Screening Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Screening Average Price by Manufactures (2015 and 2016)
2.4 Cancer Screening Market Competitive Situation and Trends
  2.4.1 Cancer Screening Market Concentration Rate
  2.4.2 Cancer Screening Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CANCER SCREENING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cancer Screening Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Screening Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Screening Price by Type (2011-2016)
3.4 United States Cancer Screening Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CANCER SCREENING SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cancer Screening Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Screening Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CANCER SCREENING MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cancer Screening Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Roche
  5.2.2 Cancer Screening Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Roche Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Fujirebio Diagnostics, Inc.
  5.3.2 Cancer Screening Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Fujirebio Diagnostics, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 BioMérieux
  5.4.2 Cancer Screening Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 BioMérieux Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Beckman Coulter
  5.5.2 Cancer Screening Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Beckman Coulter Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Clarient
  5.6.2 Cancer Screening Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Clarient Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Siemens
  5.7.2 Cancer Screening Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Siemens Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 DiaSorin
  5.8.2 Cancer Screening Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 DiaSorin Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Qiagen
  5.9.2 Cancer Screening Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Qiagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Xeptagen
  5.10.2 Cancer Screening Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Xeptagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Orion Genomics.
5.12 Hologic, Inc.
5.13 Quest Diagnostics
5.14 Oncohealth Corporation
5.15 Femasys, Inc.
5.16 Biohit Oyj
5.17 Sysmex
5.18 Immunostics
5.19 Alere

6 CANCER SCREENING MANUFACTURING COST ANALYSIS

6.1 Cancer Screening Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Screening

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cancer Screening Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Screening Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CANCER SCREENING MARKET FORECAST (2016-2021)

10.1 United States Cancer Screening Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Screening Sales Forecast by Type (2016-2021)
10.3 United States Cancer Screening Sales Forecast by Application (2016-2021)
10.4 Cancer Screening Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Screening
Table Classification of Cancer Screening
Figure United States Sales Market Share of Cancer Screening by Type in 2015
Table Application of Cancer Screening
Figure United States Sales Market Share of Cancer Screening by Application in 2015
Figure United States Cancer Screening Sales and Growth Rate (2011-2021)
Figure United States Cancer Screening Revenue and Growth Rate (2011-2021)
Table United States Cancer Screening Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Screening Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Screening Sales Share by Manufacturers
Figure 2016 Cancer Screening Sales Share by Manufacturers
Table United States Cancer Screening Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Screening Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Screening Revenue Share by Manufacturers
Table 2016 United States Cancer Screening Revenue Share by Manufacturers
Table United States Market Cancer Screening Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Screening Average Price of Key Manufacturers in 2015
Figure Cancer Screening Market Share of Top 3 Manufacturers
Figure Cancer Screening Market Share of Top 5 Manufacturers
Table United States Cancer Screening Sales by Type (2011-2016)
Table United States Cancer Screening Sales Share by Type (2011-2016)
Figure United States Cancer Screening Sales Market Share by Type in 2015
Table United States Cancer Screening Revenue and Market Share by Type (2011-2016)
Table United States Cancer Screening Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Screening by Type (2011-2016)
Table United States Cancer Screening Price by Type (2011-2016)
Figure United States Cancer Screening Sales Growth Rate by Type (2011-2016)
Table United States Cancer Screening Sales by Application (2011-2016)
Table United States Cancer Screening Sales Market Share by Application (2011-2016)
Figure United States Cancer Screening Sales Market Share by Application in 2015
Table United States Cancer Screening Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Screening Sales Growth Rate by Application (2011-2016)
Table Abbott Basic Information List
Table Abbott Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Cancer Screening Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Cancer Screening Sales Market Share (2011-2016)
Table Fujirebio Diagnostics, Inc. Basic Information List
Table Fujirebio Diagnostics, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujirebio Diagnostics, Inc. Cancer Screening Sales Market Share (2011-2016)
Table BioMérieux Basic Information List
Table BioMérieux Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMérieux Cancer Screening Sales Market Share (2011-2016)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter Cancer Screening Sales Market Share (2011-2016)
Table Clarient Basic Information List
Table Clarient Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Clarient Cancer Screening Sales Market Share (2011-2016)
Table Siemens Basic Information List
Table Siemens Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Cancer Screening Sales Market Share (2011-2016)
Table DiaSorin Basic Information List
Table DiaSorin Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table DiaSorin Cancer Screening Sales Market Share (2011-2016)
Table Qiagen Basic Information List
Table Qiagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen Cancer Screening Sales Market Share (2011-2016)
Table Xeptagen Basic Information List
Table Xeptagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Xeptagen Cancer Screening Sales Market Share (2011-2016)
Table Orion Genomics. Basic Information List
Table Orion Genomics. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orion Genomics. Cancer Screening Sales Market Share (2011-2016)
Table Hologic, Inc. Basic Information List
Table Hologic, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic, Inc. Cancer Screening Sales Market Share (2011-2016)
Table Quest Diagnostics Basic Information List
Table Quest Diagnostics Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Quest Diagnostics Cancer Screening Sales Market Share (2011-2016)
Table Oncohealth Corporation Basic Information List
Table Oncohealth Corporation Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncohealth Corporation Cancer Screening Sales Market Share (2011-2016)
Table Femasys, Inc. Basic Information List
Table Femasys, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Femasys, Inc. Cancer Screening Sales Market Share (2011-2016)
Table Biohit Oyj Basic Information List
Table Biohit Oyj Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biohit Oyj Cancer Screening Sales Market Share (2011-2016)
Table Sysmex Basic Information List
Table Sysmex Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sysmex Cancer Screening Sales Market Share (2011-2016)
Table Immunostics Basic Information List
Table Immunostics Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunostics Cancer Screening Sales Market Share (2011-2016)
Table Alere Basic Information List
Table Alere Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alere Cancer Screening Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Screening
Figure Manufacturing Process Analysis of Cancer Screening
Figure Cancer Screening Industrial Chain Analysis
Table Raw Materials Sources of Cancer Screening Major Manufacturers in 2015
Table Major Buyers of Cancer Screening
Table Distributors/Traders List
Figure United States Cancer Screening Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Screening Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Screening Production Forecast by Type (2016-2021)
Table United States Cancer Screening Consumption Forecast by Application (2016-2021)